Literature DB >> 10428995

Changing epidemiology of group B streptococcal colonization.

M E Hickman1, M A Rench, P Ferrieri, C J Baker.   

Abstract

OBJECTIVES: To define factors influencing vertical transmission of and neonatal colonization with group B streptococci (GBS) in neonates representing ethnically and economically diverse populations, and to determine the serotype distribution of isolates, especially new types IV-VIII. STUDY
DESIGN: Prospective, cross-sectional study of neonates born to women evaluated for GBS colonization at admission for delivery to one of four hospitals between January 1994 and February 1995. Cultures of throat, umbilicus, and rectum were obtained from 24- to 48-hour-old infants for isolation of GBS. Isolates were classified by capsular polysaccharide (I-VIII) and C protein (alpha and beta) antigen components.
RESULTS: Colonization was detected in 28% of 546 mothers, was higher in blacks than whites (40.6% vs 20.3%) and Hispanics (26. 9%), and was not influenced by socioeconomic status. Overall, ethnic origin did not seem to be related to GBS serotype, but whites were more likely to carry the new type V strain than blacks (6 out of 24 [25%] vs 1 out of 43 [2%]). Vertical transmission of GBS to neonates was significantly diminished when their mothers had intrapartum antibiotics (0% vs 52%), rupture of membranes <12 hours before delivery (38.4% vs 73.3%), or delivery by cesarean section (25.9% vs 45.2%). Colonization with GBS was found in 13.8% of 549 neonates, was acquired vertically in 97%, and was less frequent in neonates at the private hospitals (4% vs 20%) where intrapartum antibiotics were given more frequently (34.7% vs 17.3%). Among isolates from neonates, serotype Ia predominated (31.6%) followed by types II (25%), III (22.4%), and V (11.8%); approximately 40% of strains contained C protein antigen.
CONCLUSIONS: Changes in the epidemiology of GBS colonization included diminished rates in some populations associated with use of maternal intrapartum antibiotics, and a shift in serotype prevalence, with Ia as predominant and V, in addition to II and III, as common.

Entities:  

Mesh:

Year:  1999        PMID: 10428995     DOI: 10.1542/peds.104.2.203

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  53 in total

1.  The neonatal group B streptococcal epidemic: lessons learned from studying associations.

Authors:  Michael P Sherman; Michael S Cooperstock
Journal:  Neonatology       Date:  2011-10-18       Impact factor: 4.035

Review 2.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

3.  Sepsis-Related Mortality of Very Low Birth Weight Brazilian Infants: The Role of Pseudomonas aeruginosa.

Authors:  Sylvia Maria Porto Pereira; Maria Helena Cabral de Almeida Cardoso; Ana Lucia Figuexeds; Haroldo Mattos; Ronaldo Rozembaum; Vanessa Isidoro Ferreira; Maria Antonieta Portinho; Ana Cristina Gonçalves; Elaine Sobral da Costa
Journal:  Int J Pediatr       Date:  2010-02-21

4.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.

Authors:  Shi-Lu Luan; Margareta Granlund; Mats Sellin; Teresa Lagergård; Brian G Spratt; Mari Norgren
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Regulation of virulence by a two-component system in group B streptococcus.

Authors:  Sheng-Mei Jiang; Michael J Cieslewicz; Dennis L Kasper; Michael R Wessels
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

7.  Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci.

Authors:  Claire Poyart; Asmaa Tazi; Hélène Réglier-Poupet; Annick Billoët; Nicole Tavares; Josette Raymond; Patrick Trieu-Cuot
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

8.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

Review 9.  Laboratory detection of group B Streptococcus for prevention of perinatal disease.

Authors:  F J Picard; M G Bergeron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-16       Impact factor: 3.267

10.  Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35-37 weeks of pregnancy.

Authors:  Nabil Abdullah El Aila; Inge Tency; Geert Claeys; Bart Saerens; Ellen De Backer; Marleen Temmerman; Rita Verhelst; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2009-09-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.